Useful resources |
Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients (Cochrane Review) ABSTRACT Background: The benefits of recombinant human erythropoietin (rHuEPO) administration in dialysis patients have been demonstrated, however the optimal frequency regimen have yet to be established. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |